X Liu, A Situ, Y Kang, KR Villabroza,
Y Liao… - ACS …, 2016 - ACS Publications
Urgent intervention is required to improve the 5 year survival rate of pancreatic ductal
adenocarcinoma (PDAC). While the four-drug regimen, FOLFIRINOX (comprising irinotecan …